24-hour control of blood pressure by once daily doxazosin: a multicentre double-blind comparison with placebo

European Journal of Clinical Pharmacology

Volumn 34, Issue 6, 1988, Pages 613-618

  Smyth, P ^a   Pringle, S ^b   Jackson, G ^a   Lorimer, A R ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

adverse effects; alpha1 adrenoceptor inhibitor; doxazosin; hypertension; multicentre study

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DYSPNEA; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; HEADACHE; HUMAN; LIBIDO; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SIDE EFFECT; VERTIGO;

ADULT; AGED; BLOOD PRESSURE; CLINICAL TRIALS; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DOXAZOSIN; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; PRAZOSIN;

EID: 0023748196     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/BF00615226     Document Type: Article

References (14)

1. Postjunctional selectivity of alpha-blockade with prazosin, trimazosin and doxazosin (UK-33, 274) in man
2. A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK-33, 274) in normotensive subjects
3. Doxazosin, an alpha1-adrenoceptor antagonist: Pharmacokinetics and concentration effect relationships in man
4. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension
5. A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension
6. The pharmacological basis for the use of alpha1-adrenoceptor antagonists in the treatment of essential hypertension
7. Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors
8. Haemodynamic changes at rest and during exercise in long-term prazosin therapy of essential hypertension
9. Effect of alpha- and beta-blocker therapy on blood lipids. European experience
10. Antihypertensive treatment and serum lipoproteins
11. Prazosin update — a review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure
12. Treatment of hypertension with prazosin. An open study in general practice
13. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins
14. A multicenter trial of doxazosin in West Germany